USSTOCK.TODAY
Regular Market
Log in Sign up

Abbott Q3 Revenue Beats Estimates; Announces Plan to Spin Off Nutrition Business

The Wall Street Journal +5 ·

ABT Abbott Laboratories
$102.45 -1.55%
View chart & analysis →
  1. 1Abbott recorded Q3 revenue of $13.01 billion.
  2. 2This represents a 14.5% increase in Abbott's reported revenue compared to Q3 2025.
  3. 3Abbott announced plans to spin off its nutrition business into an independent listed company by the end of 2027.

So what's the key point?

Abbott's Q3 revenue exceeded $13.01 billion, performing better than experts expected. The company plans to separate its nutrition business into an independent company, which is important news for investors.

Source The Wall Street Journal +5 · View original ↗

Related 3-line summaries

Author invests $4,600 in three dividend stocks amid market warning signals The Motley Fool +1 · 3d agoComparison of Abbott Laboratories and Intuitive Surgical Earnings and Growth Potential The Motley Fool +1 · Oct 13Abbott holds high upside potential as a low-risk, high-quality dividend stock The Motley Fool +1 · Oct 11
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news